“…Because LTB 4 is a neutrophil product that is linked to neutrophil activation in ARDS (26), the MaR1 pathway can use this additional mechanism to regulate neutrophil recruitment and activation to protect the lung from bystander tissue injury from these "first responders." Along these lines, MaR1 reduced levels of several cytokines with known roles in recruitment and activation of neutrophils in ALI, such as GM-CSF and TNFα, which are reported to play important roles in acid-induced lung injury (27,28). Indeed, MaR1's antineutrophil actions in the lung, including P-selectin expression, were recently reported in an LPS model of lung inflammation (29).…”